Aspen Aerogels (ASPN) Misses Q3 EPS by 4c; Trims Outlook
Get Alerts ASPN Hot Sheet
Price: $14.85 +0.20%
Revenue Growth %: +64.5%
Financial Fact:
General and administrative expenses: 966.87K
Today's EPS Names:
MAXN, CSTR, ACU, More
Revenue Growth %: +64.5%
Financial Fact:
General and administrative expenses: 966.87K
Today's EPS Names:
MAXN, CSTR, ACU, More
Join SI Premium – FREE
Aspen Aerogels (NYSE: ASPN) reported Q3 EPS of ($0.13), $0.04 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $29.6 million versus the consensus estimate of $29.05 million.
GUIDANCE:
Aspen Aerogels sees FY2016 EPS of ($0.46)-($0.41), versus prior guidance of ($0.37)-($0.30) and the consensus of ($0.31). Aspen Aerogels sees FY2016 revenue of $118-121 million, versus prior guidance of $117-125 million and the consensus of $120.0 million.
For earnings history and earnings-related data on Aspen Aerogels (ASPN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Schlumberger (SLB) earnings in-line, revenue beats expectations
- Acme United (ACU) Misses Q1 EPS by 20c
- Senesco Technologies, Inc. (SNT) Reports Q1 EPS of $0.02
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!